A phase 1 clinical trial utilizing human bone marrow CD34+ stem cells for patients with retinal vascular occlusion, hereditary or non-exudative age-related macular degeneration (AMD), or retinitis pigmentosa (RP) has shown safety and feasibility.
Showing posts with label Bone Marrow. Show all posts
Showing posts with label Bone Marrow. Show all posts
Subscribe to:
Posts (Atom)